Authors: PAZDUR R LASSERE Y DIAZCANTON E HO DH

Citation: R. Pazdur et al., PHASE-I TRIAL OF URACIL-TEGAFUR (UFT) PLUS ORAL LEUCOVORIN - 28-DAY SCHEDULE, Cancer investigation, 16(3), 1998, pp. 145-151

Authors: PAZDUR R DIAZCANTON E BALLARD WP BRADOF JE GRAHAM S ARBUCK SG ABBRUZZESE JL WINN R

Citation: R. Pazdur et al., PHASE-II TRIAL OF 9-AMINOCAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 15(8), 1997, pp. 2905-2909

Authors: PAZDUR R MEYERS C DIAZCANTON E ABBRUZZESE JL PATT Y GROVE W AJANI J

Citation: R. Pazdur et al., PHASE-II TRIAL OF INTRAVENOUS CI-980 (NSC-370147) IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - MODEL FOR PROSPECTIVE EVALUATION OF NEUROTOXICITY, American journal of clinical oncology, 20(6), 1997, pp. 573-576

Authors: PAZDUR R LASSERE Y DIAZCANTON E BREADY B HO DH

Citation: R. Pazdur et al., PHASE-I TRIAL OF URACIL-TEGAFUR (UFT) PLUS ORAL LEUCOVORIN - 14-DAY SCHEDULE, Investigational new drugs, 15(2), 1997, pp. 123-128

Authors: PAZDUR R LASSERE Y DIAZCANTON E BREADY B HO DH

Citation: R. Pazdur et al., PHASE-I TRIALS OF URACIL-TEGAFUR (UFT) USING 5 AND 28 DAY ADMINISTRATION SCHEDULES - DEMONSTRATION OF SCHEDULE-DEPENDENT TOXICITIES, Anti-cancer drugs, 7(7), 1996, pp. 728-733